Point72 Asset Management’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
123,284
-1,405,250
| -92% | -$13.4M | ﹤0.01% | 933 |
|
|
2025
Q1 | $16M | Buy |
1,528,534
+603,853
| +65% | +$6.32M | 0.04% | 426 |
|
|
2024
Q4 | $21.8M | Buy |
924,681
+822,201
| +802% | +$19.4M | 0.05% | 371 |
|
|
2024
Q3 | $3.68M | Sell |
102,480
-255,038
| -71% | -$9.16M | 0.01% | 654 |
|
|
2024
Q2 | $12.6M | Sell |
357,518
-328,916
| -48% | -$11.6M | 0.03% | 450 |
|
|
2024
Q1 | $19.5M | Buy |
686,434
+297,234
| +76% | +$8.44M | 0.05% | 411 |
|
|
2023
Q4 | $5.18M | Sell |
389,200
-186,600
| -32% | -$2.48M | 0.01% | 717 |
|
|
2023
Q3 | $5.16M | Buy |
575,800
+147,271
| +34% | +$1.32M | 0.02% | 699 |
|
|
2023
Q2 | $4.82M | Sell |
428,529
-492,606
| -53% | -$5.54M | 0.01% | 680 |
|
|
2023
Q1 | $10.6M | Sell |
921,135
-466,533
| -34% | -$5.37M | 0.03% | 482 |
|
|
2022
Q4 | $16.1M | Sell |
1,387,668
-109,963
| -7% | -$1.27M | 0.05% | 374 |
|
|
2022
Q3 | $19M | Buy |
1,497,631
+131,231
| +10% | +$1.67M | 0.08% | 316 |
|
|
2022
Q2 | $9.39M | Sell |
1,366,400
-521,500
| -28% | -$3.58M | 0.04% | 465 |
|
|
2022
Q1 | $18.2M | Buy |
1,887,900
+633,100
| +50% | +$6.1M | 0.07% | 324 |
|
|
2021
Q4 | $14.9M | Buy |
1,254,800
+427,800
| +52% | +$5.09M | 0.06% | 387 |
|
|
2021
Q3 | $13.4M | Buy |
827,000
+146,100
| +21% | +$2.37M | 0.06% | 390 |
|
|
2021
Q2 | $14.3M | Buy |
680,900
+327,785
| +93% | +$6.9M | 0.06% | 344 |
|
|
2021
Q1 | $5.48M | Buy |
+353,115
| New | +$5.48M | 0.03% | 520 |
|
|
2020
Q4 | – | Sell |
-20,000
| Closed | -$404K | – | 904 |
|
|
2020
Q3 | $404K | Buy |
+20,000
| New | +$404K | ﹤0.01% | 772 |
|